Effect of Orally Administered Semaglutide Versus Dulaglutide on Diabetes-Related Quality of Life in Japanese Patients With Type 2 Diabetes: The PIONEER 10 Randomized, Active-Controlled Trial
Version 2 2021-01-06, 13:00
Version 1 2020-12-24, 08:59
figure
posted on 2021-01-06, 13:00 authored by Adis journals on behalf of, Hitoshi Ishii, Brian B. Hansen, Jakob Langer, Hiroshi Horio<p></p><p><strong>Article
full text</strong></p>
<p><br>
The article associated with this page has been accepted for
online publication and is in the final stages of production. The link to the
full text will be made available on this page in the next few days.</p>
<p><br>
The above summary slide represents the opinions of
the authors. For a full list of declarations, including
funding and author disclosure statements, please see the full text online (see
“read the peer-reviewed publication” opposite). </p>
<p>© The authors, CC-BY-NC 2021.<b>
</b></p>
<p> </p><br><p></p>
